These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 29219058)
1. Macrophage Targeted Cellular Carriers for Effective Delivery of Anti-Tubercular Drugs. Agnihotri J; Singh S; Wais M; Pathak A Recent Pat Antiinfect Drug Discov; 2017; 12(2):162-183. PubMed ID: 29219058 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment. Silva JP; Gonçalves C; Costa C; Sousa J; Silva-Gomes R; Castro AG; Pedrosa J; Appelberg R; Gama FM J Control Release; 2016 Aug; 235():112-124. PubMed ID: 27261333 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control. Hussain A; Singh S; Das SS; Anjireddy K; Karpagam S; Shakeel F Curr Drug Deliv; 2019; 16(5):400-429. PubMed ID: 30714523 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges. Ullah Z; Athar MT; Samad A Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537 [TBL] [Abstract][Full Text] [Related]
6. Nano-carriers for the Treatment of Tuberculosis. Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544 [TBL] [Abstract][Full Text] [Related]
7. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary Delivery of Anti-Tubercular Drugs Using Ligand Anchored pH Sensitive Liposomes for the Treatment of Pulmonary Tuberculosis. Bhardwaj A; Grobler A; Rath G; Goyal AK; Jain AK; Mehta A Curr Drug Deliv; 2016; 13(6):909-22. PubMed ID: 26718489 [TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis. Machelart A; Salzano G; Li X; Demars A; Debrie AS; Menendez-Miranda M; Pancani E; Jouny S; Hoffmann E; Deboosere N; Belhaouane I; Rouanet C; Simar S; Talahari S; Giannini V; Villemagne B; Flipo M; Brosch R; Nesslany F; Deprez B; Muraille E; Locht C; Baulard AR; Willand N; Majlessi L; Gref R; Brodin P ACS Nano; 2019 Apr; 13(4):3992-4007. PubMed ID: 30822386 [TBL] [Abstract][Full Text] [Related]
11. Nano-Drug Delivery Systems: Possible End to the Rising Threats of Tuberculosis. Sheikh BA; Bhat BA; Alshehri B; Mir RA; Mir WR; Parry ZA; Mir MA J Biomed Nanotechnol; 2021 Dec; 17(12):2298-2318. PubMed ID: 34974855 [TBL] [Abstract][Full Text] [Related]
12. Thioaptamer targeted discoidal microparticles increase self immunity and reduce Mycobacterium tuberculosis burden in mice. Leonard F; Ha NP; Sule P; Alexander JF; Volk DE; Lokesh GLR; Liu X; Cirillo JD; Gorenstein DG; Yuan J; Chatterjee S; Graviss EA; Godin B J Control Release; 2017 Nov; 266():238-247. PubMed ID: 28987879 [TBL] [Abstract][Full Text] [Related]
14. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review. Singh J; Garg T; Rath G; Goyal AK Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary drug delivery systems for tuberculosis treatment. Pham DD; Fattal E; Tsapis N Int J Pharm; 2015 Jan; 478(2):517-29. PubMed ID: 25499020 [TBL] [Abstract][Full Text] [Related]
16. Nanopolymersomes as potential carriers for rifampicin pulmonary delivery. Moretton MA; Cagel M; Bernabeu E; Gonzalez L; Chiappetta DA Colloids Surf B Biointerfaces; 2015 Dec; 136():1017-25. PubMed ID: 26590894 [TBL] [Abstract][Full Text] [Related]
17. A Novel Approach in Treatment of Tuberculosis by Targeting Drugs to Infected Macrophages Using Biodegradable Nanoparticles. Shivangi ; Meena LS Appl Biochem Biotechnol; 2018 Jul; 185(3):815-821. PubMed ID: 29349532 [TBL] [Abstract][Full Text] [Related]
18. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162 [TBL] [Abstract][Full Text] [Related]